| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.39B | 27.99B | 18.74B | 15.97B | 17.80B | 17.31B |
| Gross Profit | 6.29B | 10.59B | 6.49B | 5.53B | 6.51B | 4.69B |
| EBITDA | 3.62B | 7.91B | 3.44B | 2.08B | 3.33B | 2.06B |
| Net Income | 1.82B | 4.48B | 1.84B | 898.61M | 1.61B | 859.28M |
Balance Sheet | ||||||
| Total Assets | 20.29B | 25.65B | 21.54B | 19.59B | 20.21B | 20.80B |
| Cash, Cash Equivalents and Short-Term Investments | 4.19B | 4.11B | 2.55B | 1.60B | 1.33B | 1.50B |
| Total Debt | 2.21B | 2.21B | 3.85B | 4.89B | 6.25B | 6.59B |
| Total Liabilities | 7.55B | 9.39B | 8.83B | 8.76B | 11.29B | 13.39B |
| Stockholders Equity | 12.74B | 16.26B | 12.71B | 10.83B | 8.92B | 7.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.02B | 2.79B | 1.17B | 1.08B | 2.00B |
| Operating Cash Flow | 0.00 | 4.31B | 2.97B | 1.62B | 1.46B | 2.37B |
| Investing Cash Flow | 0.00 | -861.56M | -930.29M | -1.41B | -432.90M | -540.78M |
| Financing Cash Flow | 0.00 | -2.28B | -1.29B | -194.26M | -1.20B | -1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥11.68B | 3.90 | ― | 1.23% | 49.34% | 151.38% | |
73 Outperform | ¥72.34B | 9.45 | 5.37% | 3.41% | -1.40% | 13.91% | |
71 Outperform | ¥544.93B | 14.85 | ― | 2.87% | 17.41% | 10.46% | |
66 Neutral | ¥11.71B | 6.69 | 11.46% | 4.65% | 9.55% | 40.52% | |
63 Neutral | ¥35.16B | 17.69 | ― | 3.02% | 8.81% | 11.05% | |
62 Neutral | ¥95.90B | 7.40 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |